Get all office locations for this firm with a National Database subscription or New York Database subscription.

 

• Growth

 

Industries:

Life Sciences & Healthcare

Medical Device

 

Description:

OrbiMed is the world's largest healthcare-dedicated investment firm managing over $17 billion across public and private company investments worldwide. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds. OrbiMed seeks to be the capital provider of choice for life sciences companies pursuing growth and new opportunities. As a result of OrbiMed's growing capabilities in private equity, the firm launched a dedicated venture capital fund, Caduceus Private Investments, in 2000. Caduceus Private Investments II followed in 2003 and Caduceus Private Investments III was launched in 2006 with committed capital of over $500 million. In 2011 OrbiMed launched a Royalty Opportunities fund, focused on investing in healthcare royalty streams. Today, OrbiMed has a singular focus on seeking successful investments on a worldwide basis across the entire spectrum of private and publicly-traded life sciences companies. For privately-held companies, OrbiMed typically invests between $5 million and $40 million and the firm prefers mid-stage companies focused on drug development, drug discovery, and medical devices. The firm announced in Fall of 2013 the close of OrbiMed Private Investments V, LP, with just over $735 million in commitments, including approximately $36 million from the General Partner. In December 2015, the firm announced OrbiMed Private Investments VI, LP, with $950 million in limited partner commitments.

 

Funds:

Fund Name	Amount	Date
Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.